4576.T
D.Western Therapeutics Institute, Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 85.00
−1.16%Margins
Gross margin
90.1%
EBITDA margin
-147.7%
EBIT margin
-159.9%
Net margin
-163.3%
FCF margin
-128.1%
-44.0%
Return on equity
-29.1%
Return on assets
-30.3%
Return on invested capital
0.18x
Asset turnover
-JPY 493.0M
Cash from operations
JPY 32
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026